Atlas Trials

Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)

Clinical trial NCT00795899 · COMPLETED

Trial details

NCT number
NCT00795899
Sponsor
GBG Forschungs GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2002-01-01
Primary completion
2005-12-01
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.